330
Participants
Start Date
September 30, 2006
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Aripiprazole
Tablets, Oral, 2, 5, 10, or 15 mg, once daily, 52 weeks
Seaver and New York Autism Center of Excellence, New York
Richmond Behavioral Associates, Staten Island
North Shore - Long Island Jewish Health System, Bethpage
Western Psychiatric Institute and Clinic, Pittsburgh
Neuroscience, Inc, Herndon
Children's National Medical Center, Fairfax
Mission Hospitals - Mission Children's Clinics, Asheville
Virginia Treatment Center For Children, Richmond
Monarch Research Associates, Norfolk
Duke Child and Family Study Center, Durham
Child Neurology Associates, PC, Atlanta
Sarkis Clinical Trials, Gainesville
University of Florida, Gainesville
Children's Developmental Center, Winter Park
Miami Children's Hospital, Miami
Offices of Gregory Marsella, MD, PA, Boca Raton
University of South Florida, Tampa
University of Alabama at Birmingham, Birmingham
Harmonex Neuroscience, Dothan
UT Medical Group, Department Of Psychiatry, Memphis
University of Louisville, Louisville
The Nisonger Center, Columbus
University Hospitals of Cleveland, Cleveland
Children's Hospital Of Michigan, Detroit
Neurobehavioral Medicine Group, Bloomfield Hills
Children's Hospital of Wisconsin, Milwaukee
Regions Hospital, Saint Paul
University of Illinois at Chicago, Chicago
Kansas University Medical Center, Kansas City
Cutting Edge Research, Oklahoma City
Dallas Pediatric Neurology Associates, Dallas
Bayou City Research, Ltd., Houston
Red Oak Psychiatry Associates, PA, Houston
North San Antonio Healthcare Associates, San Antonio
The Children's Hospital, Aurora
Southwest Autism Research and Resource Center, Phoenix
Center for Psychiatry and Behavioral Medicine, Las Vegas
Peninsula Research Assoc, Rolling Hills Estate
Sharp Mesa Vista Hospital, San Diego
Clinical Innovations, Inc, Costa Mesa
University Of California-Davis Health Science Center, Sacramento
Pacific Institute of Medical Sciences, Bothell
Autism Spectrum Treatment and Research Center, Seattle
Univ of Arizona, Tuscon
Stanford University School Of Medicine, Stanford
Institute For Behavioral Medicine, Smyrna
Massachusetts General Hospital, Cambridge
Cambridge Health Alliance, Cambridge
Ladders Clinic, Wellsley
Children's Mercy Hospital and Clinics, Kansas City
Munroe-Meyer Institute Diagnostic Center, Omaha
Children's Specialized Hospital, Toms River
SUNY at Stony Brook - School of Medicine, Stony Brook
University of NC, Chapel Hill
University of Cincinnati, Cincinnati
Collaborators (1)
Otsuka America Pharmaceutical
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY